These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 19473629

  • 1. Beneficial effects of high-dose losartan in IgA nephritis.
    Woo KT, Chan CM, Tan HK, Choong HL, Foo M, Vathsala A, Lee EJ, Tan CC, Lee GS, Tan SH, Lim CH, Chiang GS, Fook-Chong S, Wong SK.
    Clin Nephrol; 2009 Jun; 71(6):617-24. PubMed ID: 19473629
    [Abstract] [Full Text] [Related]

  • 2. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S.
    Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643
    [Abstract] [Full Text] [Related]

  • 3. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT, Lau YK, Wong KS, Chiang GS.
    Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
    [Abstract] [Full Text] [Related]

  • 4. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy.
    Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, Kohno S.
    Hypertens Res; 2004 Dec; 27(12):963-70. PubMed ID: 15894837
    [Abstract] [Full Text] [Related]

  • 5. High dose Losartan and ACE gene polymorphism in IgA nephritis.
    Woo KT, Chan CM, Choong HL, Tan HK, Foo M, Lee EJ, Tan CC, Lee GS, Tan SH, Vathsala A, Lim CH, Chiang GS, Fook-Chong S, Yi Z, Tan HB, Wong KS.
    Genomic Med; 2008 Dec; 2(3-4):83-91. PubMed ID: 19319668
    [Abstract] [Full Text] [Related]

  • 6. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 Dec; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 7. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
    Kim HJ, Ryu JH, Han SW, Park IK, Paik SS, Park MH, Paik DJ, Chung HS, Kim SW, Lee JU.
    Nephron Physiol; 2004 Dec; 97(4):p58-65. PubMed ID: 15331931
    [Abstract] [Full Text] [Related]

  • 8. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [Abstract] [Full Text] [Related]

  • 9. Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy.
    Horita Y, Taura K, Taguchi T, Furusu A, Kohno S.
    Nephrology (Carlton); 2006 Oct; 11(5):462-6. PubMed ID: 17014562
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
    Vaz de Castro PAS, Bitencourt L, Pereira BWS, Lima AQR, Hermida HS, Moreira Neto CR, Mestriner MD, Simões E Silva AC.
    Pediatr Nephrol; 2022 Mar; 37(3):499-508. PubMed ID: 34686915
    [Abstract] [Full Text] [Related]

  • 11. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M, Tylicki L, Rutkowski P, Rutkowski B.
    Scand J Urol Nephrol; 2004 Mar; 38(5):427-33. PubMed ID: 15764256
    [Abstract] [Full Text] [Related]

  • 12. Low-dose losartan therapy reduces proteinuria in normotensive patients with immunoglobulin A nephropathy.
    Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K.
    Hypertens Res; 2008 Sep; 31(9):1711-7. PubMed ID: 18971549
    [Abstract] [Full Text] [Related]

  • 13. ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials.
    Cheng J, Zhang W, Zhang XH, He Q, Tao XJ, Chen JH.
    Int J Clin Pract; 2009 Jun; 63(6):880-8. PubMed ID: 19490198
    [Abstract] [Full Text] [Related]

  • 14. Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).
    Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    Pediatr Nephrol; 2019 May; 34(5):837-846. PubMed ID: 30284023
    [Abstract] [Full Text] [Related]

  • 15. ATRA therapy restores normal renal function and renal reserve and prevents renal failure.
    Woo KT, Lau YK, Chan CM, Wong KS.
    Ann Acad Med Singap; 2005 Jan; 34(1):52-9. PubMed ID: 15726220
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis.
    Cheng J, Zhang X, Tian J, Li Q, Chen J.
    Int J Clin Pract; 2012 Oct; 66(10):917-23. PubMed ID: 22994326
    [Abstract] [Full Text] [Related]

  • 17. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH.
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [Abstract] [Full Text] [Related]

  • 18. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
    Krairittichai U, Chaisuvannarat V.
    J Med Assoc Thai; 2009 May; 92(5):611-7. PubMed ID: 19459520
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study.
    Chen S, Yin Q, Ren S, Zhong X, Wang W, Li G, Wang L.
    Sci Rep; 2018 Sep 12; 8(1):13662. PubMed ID: 30209279
    [Abstract] [Full Text] [Related]

  • 20. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
    Li P, Chen YZ, Lin HL, Ni ZH, Zhan YL, Wang R, Yang HT, Fang JA, Wang NS, Li WG, Sun XF, Chen XM.
    Trials; 2017 Apr 11; 18(1):170. PubMed ID: 28395659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.